About CryoStasis
CryoStasis is a company based in Ottawa (Canada) founded in 2022.. CryoStasis has raised $8 million across 1 funding round from investors including Genesys Capital. CryoStasis offers products and services including Woolii™ SU Platform, Media, and Devices and Shipping Solutions. CryoStasis operates in a competitive market with competitors including Stirling Ultracold, Upkara, Cell Matters, Evia Bio and Montana Instruments, among others.
- Headquarter Ottawa, Canada
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
- Legal Name Cryostasis Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$8 M (USD)
in 1 rounds
-
Latest Funding Round
$8 M (USD), Seed
Jul 27, 2023
- Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of CryoStasis
CryoStasis offers a comprehensive portfolio of products and services, including Woolii™ SU Platform, Media, and Devices and Shipping Solutions. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Enables subzero unfrozen storage for optimal cell viability.
Formulation for short and long-term cell preservation.
Systems for maintaining cell viability during transport.
Funding Insights of CryoStasis
CryoStasis has successfully raised a total of $8M through 1 strategic funding round. The most recent funding activity was a Seed round of $8 million completed in July 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Seed — $8.0M
-
First Round
First Round
(27 Jul 2023)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2023 | Amount | Seed - CryoStasis | Valuation | Genesys Capital |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in CryoStasis
CryoStasis has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Genesys Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage life sciences companies are supported through venture capital investments.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by CryoStasis
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - CryoStasis
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Cryostasis Comparisons
Competitors of CryoStasis
CryoStasis operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Stirling Ultracold, Upkara, Cell Matters, Evia Bio and Montana Instruments, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Freezers for scientific, medical, and electronics preservation are manufactured.
|
|
| domain | founded_year | HQ Location |
Provides freeze-free stabilization for biomolecules, enabling room-temperature storage and shipping.
|
|
| domain | founded_year | HQ Location |
CDMO focused on manufacturing of cell therapy products
|
|
| domain | founded_year | HQ Location |
Non-DMSO cryopreservation technology is provided for cell therapy supply chains.
|
|
| domain | founded_year | HQ Location |
Optical measurement solutions are developed for life sciences industries.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about CryoStasis
When was CryoStasis founded?
CryoStasis was founded in 2022 and raised its 1st funding round 1 year after it was founded.
Where is CryoStasis located?
CryoStasis is headquartered in Ottawa, Canada. It is registered at Ottawa, Ontario, Canada.
Is CryoStasis a funded company?
CryoStasis is a funded company, having raised a total of $8M across 1 funding round to date. The company's 1st funding round was a Seed of $8M, raised on Jul 27, 2023.
What does CryoStasis do?
CryoStasis was founded in 2022 and is based in Ottawa, Canada. Storage solutions are provided for the preservation of biological material traces within the cryostasis sector. Operations emphasize secure handling and long-term maintenance of samples, with services tailored to research and medical applications. The companys domain, cryostasis.ca, supports its activities in the Canadian biotechnology landscape.
Who are the top competitors of CryoStasis?
CryoStasis's top competitors include Stirling Ultracold, Cell Matters and Montana Instruments.
What products or services does CryoStasis offer?
CryoStasis offers Woolii™ SU Platform, Media, and Devices and Shipping Solutions.
Who are CryoStasis's investors?
CryoStasis has 1 investor. Key investors include Genesys Capital.